- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 26 results
Client Alert
February 5, 2026
European Union Signs EU-Mercosur Free Trade Agreement
Client Alert
December 22, 2025
EUROPE - Major Regulatory Developments in Pharmaceuticals, Biotechnology, and Medical Devices
Client Alert
November 24, 2025
The Digital Omnibus Proposal: Simplifying the EU Digital Rulebook by … adding more rules?
Client Alert
September 26, 2025
The EU’s proposal to phase out Russian gas imports: legal risks and practical challenges
Thought Leadership
September 15, 2025
Dr. Salomé Cisnal de Ugarte Re-appointed as Non-Governmental Advisor (NGA) to the EU at the International Competition Network (ICN)
Client Alert
September 5, 2025
Framework Intact, For Now: EU-US Data Flows Dodge Another Bullet
Client Alert
September 4, 2025
Data Sharing in a Connected World: Does the EU Data Act Call for New Business Models?
Client Alert
July 11, 2025
FDA Publishes More Than 200 Complete Response Letters (CRLs) With More to Come
Client Alert
June 24, 2025
EUROPE – European Commission Excludes Chinese Medical Device Manufacturers from EU Public Procurement Contracts
Client Alert
Client Alert
May 20, 2025
UK Concludes Free Trade Agreement with India Offering Significant Opportunities
Client Alert
May 16, 2025
New Security Measures for Large Databases: When a DPA’s Directives Set Standards